When was LEO Pharma founded?

LEO Pharma was founded in 1908 and raised its 1st funding round 101 years after it was founded.

Where is LEO Pharma located?

LEO Pharma is headquartered in Copenhagen, Denmark.

Who is the current CEO of LEO Pharma?

Christophe Bourdon of LEO Pharma.

How many employees does LEO Pharma have?

As of May 31, 2025, the latest employee count at LEO Pharma is 142.

Is LEO Pharma a funded company?

LEO Pharma is a funded company, having raised a total of $560M across 3 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Oct 12, 2009.

When was the latest funding round of LEO Pharma?

LEO Pharma's latest funding was a $***** PE round on Mar 31, 2022, with participation from 0 investor.

What is the annual revenue of LEO Pharma?

Annual revenue of LEO Pharma is between ₹100 Cr and ₹500 Cr as on Mar 31, 2025

Where does LEO Pharma rank among its competitors?

LEO Pharma ranks 8th amongst 2579 active competitors, of which 862 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Sana Biotechnology, which secured $25M in Aug, 2026.

Who are the top competitors of LEO Pharma?

LEO Pharma's top competitors include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Among them, Sana Biotechnology secured the most recent funding round in August, 2026.

LEO Pharma - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Developer of drugs for treating dermatology diseases. It offers variety of medicines such as topical creams and ointments, oral tablets, and injectable biologics for the treatment of psoriasis, eczema, and rare diseases. The pipeline products include Tralokinumab for atopic dermatitis and Delgocitinib a topical pan-JAK inhibitor for chronic hand eczema.

Website: www.leo-pharma.com/
Social

Key Metrics

Founded Year

1908

Location

Copenhagen, Denmark

Stage

Late Stage

Total Funding

$560M in 3 rounds

Latest Funding Round

PE, Mar 31, 2022, $*****

Investors

Nordic Capital

Ranked

8^th among 2579 active competitors

Annual Revenue

₹100 - ₹500 Cr as on Mar 31, 2025

Employee Count

142 as on May 31, 2025

Investment & Acquisitions

Replay & 6 more

Similar Companies

Brinton Pharmaceuticals & 177 more

View LEO Pharma's full profile

LEO Pharma is associated with 11 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
PHARMAWORLD Holding, a.s. CIN: 60737395 , Czech Republic, Active	Jan 18, 1995	-	-
NeoLeo.eu s.r.o. CIN: 44740352 , Czech Republic, Active	Dec 09, 1991	-	-
Leo holdings s.r.o. CIN: 27413691 , Czech Republic, Active	Jan 04, 2006	-	-
Leo Medical Care s.r.o. CIN: 02517141 , Czech Republic, Active	Jan 07, 2014	-	-
Leo Pharma CIN: 0404.780.604 , Belgium, Active	Apr 01, 1967	-	28 (As on Dec 31, 2023)	-
LEO Ventures A/S CIN: 41600004 , Denmark, Deadpooled	Aug 12, 2020	-	-
LEO FONDET CIN: 11623336 , Denmark, Active	Aug 19, 1984	-	-
LEO PHARMA DISTRIBUTORS PRIVATE LIMITED CIN: U63020KL2012PTC032178 , India, Active	Sep 17, 2012	₹100 - ₹500 Cr (As on Mar 31, 2025)	188 (As on Apr 01, 2026)
LEO Holding A/S CIN: 39122251 , Denmark, Active		-	4 (As on Dec 31, 2021)
Leo Pharma A / S CIN: 56759514 , Denmark, Active	Feb 09, 1962	-	5804 (As on Dec 31, 2021)
LEO PHARMA, INC. CIN: 800485929 , United States, Active	Dec 31, 1999	-	235 (As on Dec 31, 2024)	-

LEO Pharma has raised a total funding of $560M over 3 rounds. Its first funding round was on Oct 12, 2009. LEO Pharma has 1 institutional investor.

Here is the list of recent funding rounds of LEO Pharma:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 31, 2022	2330163	PE	6613488	2877649	8759452	8449751
Mar 23, 2021	9922440	PE	1582822	6840530	6007669	2115779
Oct 12, 2009	4688505	Unattributed	2581189	2824505	4907954	7769157

Access funding benchmarks and valuations. Sign up today!

View details of LEO Pharma's funding rounds and investors

Here are the details of LEO Pharma's key team members:

Christophe Bourdon: CEO of LEO Pharma.

LEO Pharma's Board of Directors

LEO Pharma's board has 27 active members. Jukka Pekka Pertola, Christophe Dominique Luc Charles Bourdon, Paul Olivier Marie Navarre, Signe Maria Christensen, Lena Elisabeth Svanberg, Philip Eickhoff and Lars Green are part of team and Per Schmidt, Johannes Gerardus Christiaan Petrus Schikan, Gorm Milan Thamsborg, Jesper Brandgaard, Ann Berit Sveigaard, Peter Haahr, Vilhelm Johannes Kahlke, Lotte Gossmann, Franck Mareno, lawyer Morten Drewes Pedersen, Hanne Ann-Dorthe Ginderskov, Patrick O'Sullivan, Judith Blankholm, Jonas Agnblad, Ann Berit Moestrup, Karin Attermann, Jørgen Halsteen, Erling Finn Juhl Nielsen, Jesper Mailind and Niels Smidt Rastrup Andersen are independent board members.

Here is the list of LEO Pharma's board of directors:

Name	Type	Representing	Status	Duration
Jukka Pekka Pertola	Team	-	Current	5y 5m
xbxar{w	Team	-	Past	7y 2m
{pmneth	Team	-	Current	7y 1m
bs{tobt	Team	-	Current	3y 6m
zwhawnh	Team	-	Current	6y 2m
exhvxeu	Team	-	Current	8y 7m
llbgpju	Team	-	Current	1y 7m
bdtzdme	Team	-	Past	2y 8m
Per Schmidt	Independent board member	-	Current	12y 5m
gyeahru	Independent board member	-	Current	2y 6m
cwiqgfk	Independent board member	-	Current	4y 6m
fcezegi	Independent board member	-	Current	4y 9m
rzdvl{y	Independent board member	-	Current	6y 6m
drpkaed	Independent board member	-	Current	4y 2m
dqrq{rn	Independent board member	-	Current	9y 7m
ddgypjc	Independent board member	-	Current	8y 4m
bvsfzkr	Independent board member	-	Current	3y 3m
vijnfih	Independent board member	-	Current	1y 7m
wmyveju	Independent board member	-	Current	1y 1m
relvfol	Independent board member	-	Current	8y 2m
arerabf	Independent board member	-	Current	4y 7m
yjwhhnr	Independent board member	-	Current	5y 2m
okztace	Independent board member	-	Current	1y 5m
wdwjcov	Independent board member	-	Current	9y 2m
wkbzqjh	Independent board member	-	Current	5y 1m
j{xo{ci	Independent board member	-	Current	3y 2m
mnefisb	Independent board member	-	Current	6y 5m
uslafqx	Independent board member	-	Past	6y 4m
ieaxozs	Independent board member	-	Past	4y 2m
tkytsou	Independent board member	-	Past	5y 5m
bzpfq{l	Independent board member	-	Past	5y 9m
ovjjuol	Independent board member	-	Past	6y 2m
qy{wouj	Independent board member	-	Past	6y 6m
kbshmaa	Independent board member	-	Past	7y 4m
kjumhgs	Independent board member	-	Past	5y 5m
xmq{eys	Independent board member	-	Past	5y 3m
mhlrfnx	Independent board member	-	Past	6y 2m
qeepolm	Independent board member	-	Past	4y 7m
zonrcnz	Independent board member	-	Past	5y 5m
uprfvlc	Independent board member	-	Past	2y 3m
ce{lspf	Independent board member	-	Past	4y 2m
vwllgoi	Independent board member	-	Past	8y 8m
vdk{tvk	Independent board member	-	Past	3y 7m
bnubgrq	Independent board member	-	Past	1y 5m
nvhdugh	Independent board member	-	Past	1y 1m
dddymgg	Independent board member	-	Past	1y 3m
bublkyw	Independent board member	-	Past	1y 8m
zqybauf	Independent board member	-	Past	3y 6m
syqtfoe	Independent board member	-	Past	1y 2m
pii{gls	Independent board member	-	Past	6y 1m
srjeges	Independent board member	-	Past	6y 4m
bxboxhu	Independent board member	-	Past	7y 2m
bfnif{a	Independent board member	-	Past	8y 1m
uhplhux	Independent board member	-	Past	2y 5m
gta{pjt	Independent board member	-	Past	2y 2m
gpgilty	Independent board member	-	Past	3y 2m
xwmvgoc	Independent board member	-	Past	4y 1m
mpsa{jl	Independent board member	-	Past	9y 2m
yvzlvpw	Independent board member	-	Past	6y 2m
hyzucgf	Independent board member	-	Past	7y 2m
hxo{uxp	Independent board member	-	Past	6y 1m
kejrueh	Independent board member	-	Past	7y 9m
jqqlthg	Independent board member	-	Past	5y 6m
xbahbvx	Independent board member	-	Past	6y 3m
ovqadqq	Independent board member	-	Past	4y 9m
nnrpgfi	Independent board member	-	Past	7y 1m
oeweqwm	Independent board member	-	Past	1y 9m
hjcvuvi	Independent board member	-	Past	7y 9m
kighjnw	Independent board member	-	Past	7y 7m
r{qklat	Independent board member	-	Past	3y 8m

View details of LEO Pharma's Founder profiles and Board Members

LEO Pharma's employee count trend

LEO Pharma has 142 employees as of May 25. The total employee count is 373.0% more than what it was in May 24. Here is LEO Pharma's employee count trend over the years:

Uncover LEO Pharma's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LEO Pharma include Jazz Pharmaceuticals, Sana Biotechnology and Ideaya Biosciences. Here is the list of Top 10 competitors of LEO Pharma, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	81/100
2nd	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating various human diseases	$821M	Baillie Gifford, PSP Investments & 18 others	74/100
3rd	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	BVF Partners, Boxer Capital & 15 others	73/100
4th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
5th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
6th	Immuneel 2018, Bengaluru (India), Series B	Developer of T-cell therapies for the treatment of cancer	$49.8M	F-Prime Capital, True North & 23 others	72/100
7th	C4 Therapeutics 2016, Cambridge (United States), Public	Developer of small molecule drugs for treating cancer	$223M	Cobro Ventures, Perceptive Advisors & 27 others	71/100
8th	LEO Pharma 1908, Copenhagen (Denmark), Late Stage	Developer of drugs for treating dermatology diseases	$560M	Nordic Capital	71/100
9th	Erasca 2018, San Diego (United States), Public	Developer of small molecule based therapeutics for cancer	$300M	Cormorant Asset Management, Arch Venture Partners ... & 13 others	71/100
10th	Elicio 2012, Cambridge (United States), Public	Developer of vaccines for treating cancer	$47.4M	Dreavent, Efung Capital & 5 others	71/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on LEO Pharma's competitors? Click here to see the top ones

LEO Pharma has made 4 investments in companies including PellePharm and SkinVision. LEO Pharma has also acquired 3 companies including Replay and Timber Pharmaceuticals.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Apr 30, 2026	Acquisition	Replay	2021	San Diego (United States)
Aug 21, 2023	Acquisition	Timber Pharmaceuticals	2011	Woodcliff Lake (United States)
Nov 22, 2018	Investments	PellePharm	2012	Menlo Park (United States)